FridaySaturdaySunday

Conference Topics

ClinicalInterdisciplinaryAyahuascaPoster Sessions

Clinical Track

Matt Baggott, PhD: Beyond Fear: MDMA and Emotion


Michael Bogenschutz, MD: Psilocybin-Assisted Treatment for Alcohol Dependence
Robin Carhart-Harris, PhD: Brain Imaging Studies with Psilocybin and MDMA
Alicia Danforth, PhD (C): Findings from a Study on the MDMA/Ecstasy Experiences of Adults on the Autism Spectrum
Rick Doblin, Amanda Feilding, Bob Jesse, David Nichols, Bia Labate: Conference Welcome

Rick Doblin, Amanda Feilding, Bob Jesse, David Nichols: Psychedelic Research Founders Discussion

Amanda Feilding: The Beckley Foundation’s Program of Psychedelic Research
Peter Gasser, MD: LSD-Assisted Psychotherapy in the Treatment of Anxiety Secondary to Life Threatening Illness
Roland Griffiths, PhD: Johns Hopkins Psilocybin Research Project: Studies of Mystical Experience and Meditation in Healthy Volunteers, and Palliative Effects in Cancer Patients
Jim Grigsby, PhD, Marcela Ot'alora, Keren Tzarfatyl, PhD (C), Andrew Feldmár, PhD, Ben Sessa, MD, and Martin Williams, PhD: Updates on MDMA-Assisted Psychotherapy for PTSD Studies: Colorado, Israel, Canada, the UK, and Australia
Charles Grob, MD: Psilocybin at the End of Life
Stan Grof, MD: The Implications of Consciousness Research for Psychiatry, Psychology, and Psychotherapy
Dieter Hagenbach and Lucius Werthmüller: Albert Hofmann and His LSD: An Eventful Life and a Significant Discovery
Matt Johnson, PhD: Psilocybin-Facilitated Treatment for Addiction: Smoking Cessation
Michael Mithoefer, MD, and Annie Mithoefer, BSN: MDMA-Assisted Psychotherapy for PTSD: Current Research with Veterans, Firefighters, and Police Officers
David Nichols, PhD: LSD Neuroscience
David Nutt, MD: The Beckley-Imperial Psychedelic Research Program
Peter Oehen, MD: MDMA-Assisted Psychotherapy for PTSD: Results from the Swiss Pilot Study
Torsten Passie, MD: The Use of LSD, Psilocybin, and Bromo-LSD for the Treatment of Cluster Headaches
Jordi Riba, PhD: Fourteen Years of Clinical Research with Ayahuasca
Stephen Ross, MD: Psilocybin, Addiction, and End of Life
Franz Vollenweider, MD: The Neurobiology of Psychedelics: Implications for Mood Disorders

Interdisciplinary Track

Matthew Baggott, PhD: Quantitative Analysis of Narrative Reports of Psychedelic Drugs


Anthony Bossis, PhD: Love and Transcendence: Transformative Themes from Patient Experiences in the NYU Psilocybin Cancer Anxiety Study
Jose Carlos Bouso, PhD: 2C-B: Subjective Effects and Potential Clinical Uses
Brad Burge, Arianne Cohen, and Lakshmi Narayan: Repositioning Psychedelics in the Public Mind
Mary Cosimano, MSW, and Brian Richards, PsyD: Clinical Perspectives in Preparing and Managing High Dose Psilocybin Sessions: Insights from Johns Hopkins
Frank Echenhofer, PhD, Tara Samiy, PsyD, and Matt Spalding, PsyD: Systematic Methods of Exploring Psychedelic Experiences
Amy Emerson: MAPS’ Drug Development Strategy: MDMA-Assisted Psychotherapy for PTSD
Earth and Fire Erowid: State of the Stone 2013: Drugs of the Future, Now
James Fadiman, PhD: Scientific Problem Solving with Psychedelics
Andrew Feldmár: The Psychedelic Apprentice
Albert Garcia-Romeu: Psilocybin in the Treatment of Smoking Addiction: Psychological Mechanisms and Participant Account
Ingmar Gorman: An Analysis of the Working Alliance in MDMA-Assisted Psychotherapy
Jeffrey Guss MD: The NYU Training Program for Psychedelic Psychotherapy
Genesee Herzberg: The Phenomenology and Sequelae of MDMA-Assisted Psychotherapy: A Pilot Study
Julie Holland, MD: Ethical Considerations in the Medicinal Use of Psychedelics
Ilsa Jerome, PhD: Learning from Listening: Qualitative Data in MDMA-Assisted Psychotherapy Research
Robert Jesse: From the Johns Hopkins Psilocybin Findings to the Reconstruction of Religion
Matthew Johnson, PhD: Pharmacokinetics and Phenomenology of Inhaled Salvinorin A in Humans
Thomas Kingsley Brown, PhD: Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico
Sean Leneghan: A Phenomenologically Grounded Ethnographic Study of the Life-World of Ecstasy Users
Katherine MacLean: What Can Buddhist Meditation Teach Us about Psychedelic Science?
Ralph Metzner, PhD: Uses of Psychedelics in Shamanism and Psychotherapy
David Nickles: In Search of Entheogenic Molecules: Phytochemical Analysis from the DMT-Nexus
Geoff Noller, MD: Notes on Progress in the New Zealand Ibogaine Study
Peter Oehen, MD: The Essence of Psychedelic Therapy
Tomáš Páleníček: Behavioral, Neurochemical, and Pharmaco-EEG Profiles of 2C-B in Rats
Amir Raz, MD: The Neural Correlates of Altered Consciousness: From Hypnosis and Meditation to Drug-Based Changes
William Richards, PhD: Psychedelic Psychotherapy: Insights from 25 Years of Research
Doug Robinson: Why People Climb Mountains
Leonardo Rodriguez-Perez: Gaultheria Insipida: A Female Psychedelic Plant from the Andes
Austin Shaw: Creativity, Cosmology, and Communion: A Buddhist View on the Sacred Significance of Psychedelics
Ann Shulgin: Q&A Session: "Understanding the Shadow"
Sue Sisley, MD: Marijuana for PTSD: Existing Evidence and MAPS’ FDA-Approved Protocol
Diana Slattery, PhD: Communicating the Unspeakable: Linguistic Phenomena in the Psychedelic Sphere
Luke Williams: The Effects of Psilocybin and MDMA on Resting State Hippocampal Functional Connectivity
Phil Wolfson, MD: The Varieties of Ketamine Experience

Ayahuasca Track

Organized by Beatriz Caiuby Labate
Moderated by Kenneth W. Tupper, Brian Anderson, and Anya Loizaga-Velder

Brian Anderson, MSc, MD (C): Classifying Ayahuasca: The Role of Subjective Experience in Psychiatric Research with Psychedelics


Dráulio Barros de Araujo, PhD: Linking Ayahuasca, Mental Imagery, and Internal Attention with Functional Neuroimaging
Stephan Beyer, PhD, JD: Ayahuasca, the Scientific Paradigm, and Shamanic Healing
Marc Blainey, PhD (C): Ayahuasca Therapy and Santo Daime Mysticism in Europe: Ethnographic Challenges to Prohibition
José Carlos Bouso, PhD: Ayahuasca and the Treatment of Drug Addiction: A Review of the Evidence and Proposals for the Future
José Carlos Bouso, PhD: Long-Term Effects of the Ritual Use of Ayahuasca on Mental Health
Jeffrey Bronfman: Federal Government Licensing of Ayahuasca Use and Personal and Religious Freedom
Clancy Cavnar, PsyD: The Effects of Participation in Ayahuasca Rituals on Gay’s and Lesbian’s Self Perception
Josep María Fábregas, MD: Ayahuasca: Dope or Medicine?
Kevin Feeney, JD, and Beatriz Caiuby Labate, PhD: The Expansion of Brazilian Ayahuasca Religions: Law, Culture, and Locality
Eduardo Gastelumendi, MD: A Psychoanalytic Perspective on Ayahuasca: Insight, Transitional Space, and Potential Side Effects
Alex Gearin, PhD (C): A Comparative Analysis of Ayahuasca Healing in Amazonia and Australia
Mitch Liester, MD and James Prickett, DO: Four Hypotheses Regarding Ayahuasca’s Mechanisms of Action in the Treatment of Addictions
Anya Loizaga-Velder, PhD (C): The Therapeutic Potential of Ritual Ayahuasca Use for the Treatment of Substance Dependencies
Jacques Mabit, MD: Twenty Years at Takiwasi: Reflections on the Spiritual Dimension as the Interface Between Drug Addiction and Traditional Amazonian Medicine
Gabor Mate, MD: Psychedelics in Unlocking the Unconscious: From Cancer to Addiction
Dennis J. McKenna, PhD: Ayahuasca Admixture Plants: An Uninvestigated Folk Pharmacopoeia
Ethan McIlhenny, PhD: Ayahuasca Characterization, Metabolism in Humans, and Relevance to Endogenous N,N-Dimethyltryptamines
Matthew Meyer, PhD (C): Currents, Fluids, and Forces: The Esoteric Origins of Santo Daime Theories of Healing
Jessica L. Nielson, PhD and Julie D. Megler, MSN, NP-BC: Ayahuasca for PTSD: Integrating Psychedelic Therapeutic Strategies for Neurotrauma into a Bioinformatics Framework
Jordi Riba, PhD: Fourteen Years of Clinical Research with Ayahuasca
Sidarta Ribeiro, PhD: How Similar to Dreaming is the Ayahuasca Experience?
Brian Rush, PhD: Evaluating the Therapeutic Potential of Ayahuasca for Substance Use Problems
Joe Tafur, MD: Integrating the Modern Practice of Traditional Ayahuasca Shamanism
Gerald Thomas, PhD, Philippe Lucas, MA, N. Rielle Capler, MHA, and Kenneth Tupper, PhD: Ayahuasca-Assisted Therapy in the Treatment of Addiction in a Canadian First Nations Band
Luís Fernando Tófoli, MD, PhD: A Survey of Quality of Life and Antidepressant Use in Brazilian Members of the União do Vegetal
Kenneth Tupper, PhD: The Economics of Ayahuasca
Jan Weinhold, PhD: Santo Daime in Europe: Ritual Transfer and Cultural Translations


Ayahuasca Community Forum: Ethical and Safety Reflections by the Global Community - Moderated by Rak Razam, Sitaramaya and Stephan Beyer
Ayahuasca Researchers Dialogue: Organized and Moderated by Philippe Lucas
“AYA: Awakenings” Documentary Film Screening and Discussion: Directed by Rak Razam and Tim Parish

Poster Sessions

Poster sessions will be held on Friday, April 19, from 12:00 pm - 1:30 pm

Juan Acosta-Urquidi: QEEG Studies of the Effects of Natural and Synthetic DMT


Peter Addy: The Phenomenology of Salvia Divinorum Inebriation
Matthew Bradstreet: Characterization of Challenging Experiences (i.e., Bad Trips) After Ingesting Psilocybin
Nicholas Cozzi: Indolethylamine N-methyltransferase Expression in Primate Nervous Tissue
Vanja Dakic: Pluripotent Stem Cells as Tools for Studying the Effects of Psychedelic Substances in Human Neurons
Alan Davis: The Prevalence, Intensity, and Assessment of Craving for MDMA/Ecstasy in Recreational Users
Nese Devenot: Interdisciplinary Trends in Contemporary Psychedelic Conferences
Gantt Galloway: Ketamine Reduces Negative Affect: Results of a Web-Based Survey
Elyse Mergenthaler: Shambhala, the Hyperborean Land and Amanita Muscaria
Alan Rockefeller: Psilocybe allenii: A New Bluing Species from the Pacific Coast, USA
Andrew Sewell: Cannabinoid Augmentation of Extinction Learning
Hector Vargas-Perez: Role of Mesolimbic 5-HT2C/A Receptors in Opiate Withdrawal Motivation in Animal Models of Addiction
Zack Walsh: Use of Cannabis to Treat Symptoms of Anxiety and Depression: Results from a Survey of Canadian Medical Cannabis Users
Jan Weinhold: Psychedelic Harm Reduction: Psychometric Assessment of Substance-Related Risks with the Heidelberg Drug Questionnaire

Continuing Education () credits for psychologists, social workers, MFTs, and nurses are provided by the Spiritual Competency Resource Center which is co-sponsoring this program and is approved by the American Psychological Association to sponsor continuing education. SCRC maintains responsibility for the program and its content. SCRC is a California Board of Registered Nursing Provider (BRN) and a Board of Behavioral Sciences Provider (BBS). No need to preregister; all forms will be available at the conference site. For questions about CE, visit the SCRC website or contact David Lukoff, PhD at .(JavaScript must be enabled to view this email address) or 707-763-3576.